PortfoliosLab logoPortfoliosLab logo
GERM vs. PSCH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GERM vs. PSCH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Invesco S&P SmallCap Health Care ETF (PSCH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*

PSCH

1D
1.28%
1M
-0.71%
YTD
1.80%
6M
-1.68%
1Y
10.18%
3Y*
0.45%
5Y*
-5.72%
10Y*
6.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. PSCH - Yearly Performance Comparison


2026 (YTD)20252024
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%
PSCH
Invesco S&P SmallCap Health Care ETF
1.80%-0.49%-2.06%

GERM vs. PSCH - Sectors Allocation Comparison


Sectors
GERM
PSCH

Healthcare

99.3%
97.3%

Financial Services

0.4%
1.1%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

0.7%

Real Estate

-

-

Technology

-

1.7%

Utilities

-

-

Healthcare

GERM
99.3%
PSCH
97.3%

Financial Services

GERM
0.4%
PSCH
1.1%

Basic Materials

GERM

-

PSCH

-

Communication Services

GERM

-

PSCH

-

Consumer Cyclical

GERM

-

PSCH

-

Consumer Defensive

GERM

-

PSCH

-

Energy

GERM

-

PSCH

-

Industrials

GERM

-

PSCH
0.7%

Real Estate

GERM

-

PSCH

-

Technology

GERM

-

PSCH
1.7%

Utilities

GERM

-

PSCH

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GERM vs. PSCH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GERM

PSCH
PSCH Risk / Return Rank: 1717
Overall Rank
PSCH Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
PSCH Sortino Ratio Rank: 1717
Sortino Ratio Rank
PSCH Omega Ratio Rank: 1717
Omega Ratio Rank
PSCH Calmar Ratio Rank: 1717
Calmar Ratio Rank
PSCH Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GERM vs. PSCH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GERM vs. PSCH - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


GERMPSCHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.25

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.51

Drawdowns

GERM vs. PSCH - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum PSCH drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for GERM and PSCH.


Loading charts...

Drawdown Indicators


GERMPSCHDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-46.32%

+46.32%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

-15.36%

+15.36%

Max Drawdown (3Y)

Largest decline over 3 years

-22.98%

Max Drawdown (5Y)

Largest decline over 5 years

-46.32%

Max Drawdown (10Y)

Largest decline over 10 years

-46.32%

Current Drawdown

Current decline from peak

0.00%

-30.59%

+30.59%

Average Drawdown

Average peak-to-trough decline

0.00%

-13.46%

+13.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

5.54%

-5.54%

Volatility

GERM vs. PSCH - Volatility Comparison

The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while Invesco S&P SmallCap Health Care ETF (PSCH) has a volatility of 4.19%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GERMPSCHDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

4.19%

-4.19%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

14.06%

-14.06%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

20.26%

-20.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

22.89%

-22.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

23.63%

-23.63%

GERM vs. PSCH - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than PSCH's 0.29% expense ratio.


Dividends

GERM vs. PSCH - Dividend Comparison

GERM has not paid dividends to shareholders, while PSCH's dividend yield for the trailing twelve months is around 0.01%.


PositionTTM2025202420232022202120202019201820172016
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PSCH
Invesco S&P SmallCap Health Care ETF
0.01%0.04%0.27%0.01%2.27%0.00%0.00%0.00%0.00%0.00%0.03%

Frequently Asked Questions


PSCH has higher volatility (4.19%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs PSCH's -46.32%.

On 1-year performance, PSCH leads with 10.18% vs 0.00% for GERM. On fees, PSCH is cheaper at 0.29% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, PSCH has performed better with a 10.18% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PSCH is cheaper with a 0.29% expense ratio, compared with 0.68% for GERM.

PSCH has the higher dividend yield at 0.01%, compared with 0.00% for GERM.

GERM tracks Prime Treatments, Testing and Advancements Index, while PSCH tracks S&P SmallCap 600 Health Care Index. They also come from different issuers: Amplify and Invesco. Their fees differ too: 0.68% for GERM and 0.29% for PSCH.

Portfolio Optimizer

Find the right allocation for GERM and PSCH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer